D

Duopharma Biotech Bhd
KLSE:DPHARMA

Watchlist Manager
Duopharma Biotech Bhd
KLSE:DPHARMA
Watchlist
Price: 1.3 MYR -1.52% Market Closed
Market Cap: 1.3B MYR

Profitability Summary

Duopharma Biotech Bhd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Duopharma Biotech Bhd

Margins Comparison
Duopharma Biotech Bhd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
MY
Duopharma Biotech Bhd
KLSE:DPHARMA
1.3B MYR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
977.5B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
272.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.5B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
144.7B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Duopharma Biotech Bhd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
MY
Duopharma Biotech Bhd
KLSE:DPHARMA
1.3B MYR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
977.5B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
272.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
144.7B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Duopharma Biotech Bhd

Last Value
3-Years Average
FCF Margin
Conversion Rate